[Radiotherapy of malignant obstructive jaundice]

Area of Science:

• Oncology
• Radiotherapy
• Medical Physics

Context:

• Malignant obstructive jaundice presents significant treatment challenges.
• Current treatment modalities include brachytherapy and percutaneous irradiation.
• Tumor characteristics, such as bile duct and Klatskin tumors, influence treatment strategy.

Purpose:

• To evaluate the combined use of brachytherapy and percutaneous irradiation for malignant obstructive jaundice.
• To discuss the technical aspects and indications for different radiotherapy techniques.
• To highlight the importance of careful dose planning and patient selection.

Summary:

• Brachytherapy with iridium 192 and percutaneous irradiation with 16 MV photons are key radiotherapy techniques for malignant obstructive jaundice.
• A combination of endoluminal brachytherapy for intraluminal tumors and 3D-planned percutaneous irradiation for extraluminal disease and lymph nodes is often advantageous.
• Intraoperative radiotherapy may be used as a booster in select cases.
• High target doses required for solid tumors necessitate careful consideration of potential side effects, often limiting treatment to palliative settings.

Impact:

• Optimized radiotherapy strategies can improve palliative care for patients with malignant obstructive jaundice.
• Understanding the benefits and limitations of combined radiotherapy approaches is essential for clinical decision-making.
• This approach aims to improve local tumor control and patient outcomes within the constraints of palliative care.